IBB Holdings Information

IBB is an equity ETF with a total of 252 individual holdings. The top holdings are Vertex Pharmaceuticals stock at 7.61%, Amgen at 7.50%, Gilead Sciences at 7.11%, Regeneron Pharmaceuticals at 6.58%, and Alnylam Pharmaceuticals at 4.23%.

Total Holdings

Top 10 Percentage

47.95%

Asset Class

Equity

ETF Category

Health

Assets

8.40B

PE Ratio

23.50

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	VRTX	Vertex Pharmaceuticals Incorporated	7.61%	1,422,009
2	AMGN	Amgen Inc.	7.50%	1,932,621
3	GILD	Gilead Sciences, Inc.	7.11%	4,922,015
4	REGN	Regeneron Pharmaceuticals, Inc.	6.58%	737,020
5	ALNY	Alnylam Pharmaceuticals, Inc.	4.23%	905,818
6	INSM	Insmed Incorporated	3.53%	1,491,725
7	IQV	IQVIA Holdings Inc.	3.21%	1,216,172
8	ARGX	argenx SE	3.19%	310,437
9	NTRA	Natera, Inc.	2.56%	954,775
10	MTD	Mettler-Toledo International Inc.	2.43%	147,592
11	BIIB	Biogen Inc.	2.16%	1,056,055
12	WAT	Waters Corporation	1.92%	428,635
13	UTHR	United Therapeutics Corporation	1.92%	315,705
14	ILMN	Illumina, Inc.	1.66%	1,078,327
15	ONC	BeOne Medicines AG	1.64%	449,570
16	INCY	Incyte Corporation	1.62%	1,392,315
17	GMAB	Genmab A/S	1.23%	3,267,570
18	NBIX	Neurocrine Biosciences, Inc.	1.17%	696,317
19	MEDP	Medpace Holdings, Inc.	1.09%	163,733
20	RVMD	Revolution Medicines, Inc.	1.07%	1,169,174
21	IONS	Ionis Pharmaceuticals, Inc.	1.05%	1,140,759
22	BBIO	BridgeBio Pharma, Inc.	1.03%	1,170,185
23	MDGL	Madrigal Pharmaceuticals, Inc.	0.95%	145,519
24	EXEL	Exelixis, Inc.	0.94%	1,880,944
25	MRNA	Moderna, Inc.	0.90%	2,479,232

Showing 25 of 252 holdings

Subscribe to see the full list

Activate Now

As of Dec 17, 2025